|
Título:
|
Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): data from the Peruvian Almenara Lupus Cohort
|
|
Autores:
|
Ugarte-Gil, M.F. ;
Gamboa-Cárdenas, R.V. ;
Reátegui-Sokolova, C. ;
Pimentel-Quiroz, V.R. ;
Zeña-Huancas, P. ;
Elera-Fitzcarrald, C. ;
Garcia-Hirsh, S. ;
Gil, L. ;
Pastor-Asurza, C.A. ;
Rodriguez-Bellido, Z. ;
Merrill, J. ;
Askanase, A.D. ;
Alarcon, G. ;
Perich-Campos, R.A.
|
|
Tipo de documento:
|
texto impreso
|
|
Editorial:
|
BMJ Publishing Group, 2020-12-14T16:10:21Z
|
|
Nota general:
|
info:eu-repo/semantics/restrictedAccess
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
|
|
Idiomas:
|
Inglés
|
|
Palabras clave:
|
Editados por otras instituciones
,
Artículos
,
Artículos en revistas indizadas
|
|
Resumen:
|
Objective The Lupus Foundation of America Rapid Evaluation of Activity in Lupus (LFA-REAL) clinician-reported outcome (ClinRO) and the LFA-REAL patient-reported outcome (PRO) were developed in order to capture manifestations of SLE from the perspective of both the clinician and the patient. The aim of this study is to compare the LFA-REAL ClinRO and PRO with other lupus disease activity measures. Methods A cross-sectional analysis of patients from a single-centre cohort was performed using Spearman's correlation. Disease activity measures included were LFA-REAL ClinRO (range 0-1400), LFA-REAL PRO (range 0-1200), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), clinical SLEDAI-2K and Physician Global Assessment (PGA, range 0-100). Results Two hundred and twenty-seven patients with SLE were studied. The mean age was 46.3 (SD: 13.8); 212 (93.4%) were female. The mean (SD) LFA-REAL ClinRO was 25.4 (34.7), LFA-REAL PRO was 241.1 (187.6), PGA was 11.9 (15.4), SLEDAI-2K was 2.3 (3.3) and clinical SLEDAI-2K was 1.6 (2.9). The LFA-REAL ClinRO correlated with PGA (r=0.758, p
|
|
En línea:
|
http://repositorio.upch.edu.pe/handle/upch/8836
|
